Immunotech Laboratories Inc (IMMB)

[crude-dude]

On March 9, 2017, the Company (ECPO) entered into an agreement with the shareholders of Immunotech Laboratories, Inc. (Immunotech) to acquire all of the outstanding shares, both preferred and common stock, of Immunotech for 60,000,000 shares of the Company’s Series A preferred stock. The current shareholders of Immunotech ownership, not less than 80% of the issued and outstanding shares of ECPO common stock at any given time. At the effective time of the Acquisition, all options to acquire common stock of Immunotech issued and outstanding, whether vested or unvested, shall automatically be converted into and become options to purchase shares of Common Stock. Immunotech’s 200 Million outstanding Series B Preferred convert one to one but do have a voting preference and shall be exchanged for 200 Million Series B Preferred shares of ECPO with the exact same voting preferences as the Immunotech Series B Preferred. The Series B outstanding will be included in the 80% calculation for the Newly Created Preferred.
================================
All this and no 8K?